Company profile: Precision BioSciences
1.1 - Company Overview
Company description
- Provider of ARCUS genome editing technology using sequence-specific nucleases to modify DNA in living cells and tissues, a Manufacturing Center for Advanced Therapeutics for production of advanced therapies, PBGENE-HBV targeting chronic hepatitis B, and partnerships for in vivo gene editing and ex vivo CAR T-cell therapy development.
Products and services
- In Vivo Gene Editing Partnerships: Human-in vivo collaborations leveraging ARCUS to edit DNA directly inside the body for therapeutic applications
- ARCUS Genome Editing: A proprietary genome editing platform built on sequence-specific nucleases to modify DNA in living cells and tissues
- Ex Vivo CAR T Partnerships: Ex vivo partnerships architect CAR T-cell products by genetically modifying T cells outside the body before reintroduction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Precision BioSciences
Neogen
HQ: United States
Website
- Description: Provider of food and animal safety products, developing, manufacturing and marketing a diverse line dedicated to food and animal safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neogen company profile →
RoslinCT
HQ: United Kingdom
Website
- Description: Provider of cell therapy CDMO services, including cGMP clinical and commercial manufacturing; process and analytical development; iPSC cell line development and manufacture; and CRISPR-edited cell therapy product development. Offers expertise across cell types, genetic modification, cell expansion, and analytical testing (multi-color flow cytometry, ELISA, qPCR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RoslinCT company profile →
Sense Biodetection
HQ: United Kingdom
Website
- Description: Provider of molecular diagnostics, developing novel, user-centered handheld tests for infections and oncology, including Veros COVID-19, an instrument-free rapid COVID-19 test delivering results in about 15 minutes at the point of care without the need for specialized laboratory equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sense Biodetection company profile →
BioIVT
HQ: United States
Website
- Description: Provider of biological and in vitro products and services for biopharmaceutical, diagnostic, and biotechnology organizations. Offerings include in vivo ADME/PK studies, bioanalytical services, biospecimen characterization, consulting for drug R&D, long-term hepatocyte culture systems (HEPATOPAC and HEPATOMUNE), and Human AB Serum for cell culture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioIVT company profile →
ViroGates
HQ: Denmark
Website
- Description: Provider of suPARnostic blood test products for better triaging in hospitals, primarily used in emergency departments for risk stratification to improve patient care, reduce healthcare costs, and empower clinical staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViroGates company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Precision BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Precision BioSciences
2.2 - Growth funds investing in similar companies to Precision BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Precision BioSciences
4.2 - Public trading comparable groups for Precision BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →